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GATA1 mutation analysis by pyrosequencing
Presence of GATA1 exon 2 mutations detected by NGS was tested by pyrosequencing using an independent aliquot of DNA. PCR primers and conditions are set out in Supplemental Table 7 . 10 µl PCR product was run in triplicate or quadruplicate. Single-stranded PCR product was obtained using a biotinylated PCR primer (Supplemental Table 7 ), immobilised on streptavidin beads, denatured with NaOH and then annealed to a sequencing primer (Supplemental Table 8 ) by heating to 80ºC for 2 minutes. Pyrosequencing was run on a PyroMark Q96 MD (Qiagen, Hilden, Germany) (dispensation orders -Supplemental Table 8 ). The proportion of mutant allele was measured for two to four bases in each sample. These were then averaged.
Sensitivity and specificity of deep sequencing were tested using serial DNA dilutions of a male ML-DS cell line with a hemizygous GATA1 mutation and normal cord blood (Supplemental Table 1 ). Mutation quantitation from deep sequencing (3-5x10 5 mapping reads analysed/sample) was compared with pyrosequencing. The limit of detection of mutant GATA1 sequence was ~1% by pyrosequencing and ~0·3% by deep sequencing.
Blast cell immunophenotyping
Mononuclear cells (MNC) were isolated by Ficoll density gradient separation from peripheral blood samples from 7 DS neonates without TAM where next-generationsequencing of DNA from the same samples was performed. Two patients were subsequently found to have a GATA1 mutation (silent TAM) and 5 had no GATA1 mutations detected on NGS. Results were compared with 8 anonymised samples from neonates without DS and 7 samples with a confirmed diagnosis of TAM as defined in the OIDSC study. CD34+ enriched populations were purified using magnetic beads (Miltenyi, Bisley UK) from MNC and stained with PerCP-CD34 (BioLegend, San Diego, USA), PE-Cy5-CD7, PE-Cy7-CD33 and FITC-CD36 (eBioscience, Hatfield, UK). Dead cells were excluded using Hoechst 33258 (Invitrogen). Appropriate unstained, single-stained and fluorescence minus one controls were used to determine compensation, background staining and gating for each population. Analysis was performed using the FACS ARIA II (Becton Dickinson) and the FACS DIVA software (Becton Dickinson). ** Giant platelets and megakaryocyte fragments were defined by their diameter of >4µM but <8 µM) and >8µM) respectively 2 .
Effect of mutation
*** Dysplastic neutrophils and monocytes were identified based on the EWOG criteria 1 . 
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